These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7786770)
21. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients. Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651 [TBL] [Abstract][Full Text] [Related]
22. Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia. Shimamoto Y; Ono K; Sano M; Matsuzaki M; Suga K; Sueoka E; Tokioka T; Yamaguchi M; Suzuki H; Sato H Cancer; 1989 Jan; 63(2):289-94. PubMed ID: 2910433 [TBL] [Abstract][Full Text] [Related]
23. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers. Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236 [TBL] [Abstract][Full Text] [Related]
24. Expression of fos proto-oncogene product by monoclonal antibody FO-120 in smouldering adult T-cell leukaemia (ATL). Iwahashi M; Otsuka M; Shimotakahara S; Uozumi K; Hanada S; Arima T; Matsumoto M Br J Haematol; 1994 Jan; 86(1):193-4. PubMed ID: 8011529 [TBL] [Abstract][Full Text] [Related]
25. Serum beta 2-microglobulin in patients with adult T-cell leukemia. Tsuda H; Ishii T; Sawada T; Takatsuki K Acta Haematol; 1991; 86(1):31-5. PubMed ID: 1950359 [TBL] [Abstract][Full Text] [Related]
26. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia. Itälä M; Pelliniemi TT; Remes K Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522 [TBL] [Abstract][Full Text] [Related]
27. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment]. Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427 [TBL] [Abstract][Full Text] [Related]
28. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma. Owatari S; Otsuka M; Uozumi K; Takeshita T; Hanada S Int J Hematol; 2007 Jan; 85(1):32-5. PubMed ID: 17261499 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527 [TBL] [Abstract][Full Text] [Related]
30. Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients. O'Neill KL; Zhang F; Li H; Fuja DG; Murray BK Leukemia; 2007 Mar; 21(3):560-3. PubMed ID: 17252017 [No Abstract] [Full Text] [Related]
31. Adult T-cell leukaemia/lymphoma can mimic other lymphomas in a non-endemic area: dilemmas in diagnosis and treatment. Huang CT; Lee YH; Chow KC; Yang CF; Chen PC; Hsiao LT; Gau JP; Tzeng CH; Liu CY; Chiou TJ Intern Med J; 2014 Apr; 44(4):374-83. PubMed ID: 24533861 [TBL] [Abstract][Full Text] [Related]
32. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957 [TBL] [Abstract][Full Text] [Related]
34. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia. Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149 [TBL] [Abstract][Full Text] [Related]
35. Increased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis. Musto P; Modoni S; Ladogana S; Salcuni G; Fusilli S; Carotenuto M Leuk Lymphoma; 1993 Jan; 9(1-2):121-4. PubMed ID: 8477191 [TBL] [Abstract][Full Text] [Related]
36. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia. Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770 [TBL] [Abstract][Full Text] [Related]
37. Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Panoskaltsis N; Reid CD; Knight SC Leukemia; 2003 Apr; 17(4):716-30. PubMed ID: 12682629 [TBL] [Abstract][Full Text] [Related]
38. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children]. Pituch-Noworolska A Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Shimoyama M Br J Haematol; 1991 Nov; 79(3):428-37. PubMed ID: 1751370 [TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features. Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]